DOP033. Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.